Mark Fields

Company: Yale School of Medicine

Job title: Co-Founder, FerRx Bio & Associate Professor of Ophthalmology

Seminars:

1:00 Structure Versus Function: Debating the Most Meaningful Endpoints to Drive Regulatory Confidence and Accelerate Dry AMD and Geographic Atrophy Trials 1:10 pm

As clinical development in dry AMD and geographic atrophy accelerates, the field remains divided on how best to define success. Should structural imaging biomarkers take precedence for their quantifiability, or do functional endpoints better capture what truly matters to patients? While OCT-based metrics like hypertransmission and EZ loss may offer precision, they are unable to reflect visual…Read more

day: Pre-Conf Workshop Day